Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

Using a CRISPR-based biosensor platform, researchers have detected microRNA biomarkers of Alzheimer’s disease, with the ...

CRISPR/Cas-based biosensors offer an opportunity to quantify neuroinflammation in Parkinson’s disease, advancing diagnostics and disease monitoring.